6.1 Transient Tachypnea of the Newborn (TTN) & Respiratory Distress Syndrome (RDS)

Transient Tachypnea of the Newborn (TTN) & Respiratory Distress Syndrome (RDS)

Physiology of Neonatal Pulmonary Transition

Successful transition from intrauterine to extrauterine life requires a rapid shift from a fluid-filled lung to an air-filled, functional organ. In utero, the fetal lung actively secretes fluid at a rate of 4 to 5 mL/kg/hour to maintain expansion and promote normal lung development. This fluid is rich in chloride and low in protein.

During late gestation and particularly with the onset of labor, the maternal catecholamine and glucocorticoid surge triggers a dramatic shift. The neonatal lung epithelium transitions from active chloride and fluid secretion to active sodium and fluid absorption. This process is mediated by the activation of epithelial sodium channels (ENaC) on the apical surface of alveolar type II cells. Sodium is pumped out of the alveoli, and water follows passively into the pulmonary interstitium, where it is cleared by the pulmonary lymphatics and thoracic venous system.

---

Transient Tachypnea of the Newborn (TTN)

Transient Tachypnea of the Newborn (TTN), also historically referred to as Respiratory Distress Syndrome Type II or "wet lungs," is a benign, self-limiting condition primarily affecting term and late-preterm infants.

Pathophysiology & Etiology

The primary pathophysiological mechanism of TTN is the delayed clearance of fetal lung fluid. When fluid clearance is delayed, the fluid remains in the alveolar spaces, resulting in alveolar hypoventilation, decreased lung compliance, and ventilation-perfusion ($V/Q$) mismatch.

The most significant risk factor for TTN is Cesarean delivery without labor. Without the labor process, the infant is deprived of the compressive "thoracic squeeze" through the birth canal, which normally expels up to 30 mL of fluid. More importantly, the lack of labor prevents the maternal catecholamine surge necessary to upregulate and activate ENaC channels, leading to failed fluid resorption.

Other key risk factors include:

• Maternal diabetes: High fetal insulin levels delay the maturation of ENaC channels and surfactant-associated proteins.
• Maternal asthma: Associated with altered adrenergic receptor sensitivity.
• Precipitous labor: Rapid delivery prevents adequate time for fluid clearance.
• Maternal sedation: Depresses neonatal respiratory effort, delaying fluid clearance.
• Male gender and macrosomia.

Clinical Presentation

Infants with TTN typically present within the first 2 hours of life with:

• Tachypnea: Respiratory rate > 60 breaths/minute, frequently reaching 100 to 120 breaths/minute.
• Mild grunting, nasal flaring, and retractions: Used to maintain end-expiratory pressure and stabilize the chest wall.
• Cyanosis or oxygen requirement (typically low, FiO2 < 40%).

Diagnostic Imaging

Chest radiography is the gold standard for diagnosing TTN. Classic findings include:

• Prominent perihilar streaking: Represents engorged lymphatic vessels clearing fluid.
• Fluid in the interlobar fissures (specifically the minor fissure on the right side).
• Hyperaeration: Hyperexpanded lungs, visible as flat diaphragms and 9 or more posterior ribs visible.
• Mild cardiomegaly (due to fluid volume).

Clinical Course & Management

TTN is self-limiting and typically resolves within 24 to 72 hours as lymphatic clearance of fluid is completed. Management is supportive:

1. Respiratory Support: CPAP (5 to 6 cmH2O) is highly effective. The positive pressure splints the alveoli open and pushes the remaining fluid across the alveolar membrane into the interstitial spaces for absorption.
2. Supplemental Oxygen: Used to maintain target oxygen saturations (90% to 95%).
3. Nutritional Management: Feedings should be guided by respiratory rate. If the respiratory rate is 80 breaths/minute or greater, the infant should be kept NPO (nothing by mouth) with IV fluids initiated. This prevents fatigue and minimizes the risk of aspiration. If the rate is 60 to 80 breaths/minute, gavage (nasogastric/orogastric) feedings may be considered.

---

Respiratory Distress Syndrome (RDS)

Respiratory Distress Syndrome (RDS), formerly called Hyaline Membrane Disease, is a major cause of morbidity and mortality in premature infants, with incidence increasing exponentially as gestational age decreases.

Pathophysiology & Etiology

The primary etiology of RDS is a deficiency of pulmonary surfactant combined with structural immaturity of the developing lung. Surfactant is a complex lipoprotein synthesized and secreted by Type II pneumocytes. While surfactant synthesis begins around 24 weeks gestation, mature and abundant levels are typically not present until 35 to 36 weeks.

Surfactant Composition:

• 90% Lipids: The primary phospholipid is dipalmitoylphosphatidylcholine (DPPC), which is responsible for lowering surface tension. Other lipids include phosphatidylglycerol (PG), which facilitates the spread of surfactant across the alveolar surface.
• 10% Proteins: Includes surfactant-associated proteins SP-A, SP-B, SP-C, and SP-D. The hydrophobic proteins SP-B and SP-C are critical for the biophysical activity of surfactant. A congenital mutation causing SP-B deficiency is a rare, fatal autosomal recessive disorder presenting as severe, refractory respiratory failure at term.

Mechanism of Action: Surfactant lowers alveolar surface tension at the air-liquid interface. Under the Law of Laplace: $P = \frac{2T}{r}$ (where $P$ is pressure, $T$ is surface tension, and $r$ is alveolar radius)

Without surfactant, surface tension ($T$) remains constant and high. As the radius ($r$) of the alveolus decreases during expiration, the pressure ($P$) required to keep the alveolus open increases dramatically. This leads to progressive alveolar collapse (atelectasis) at end-expiration. The resulting lung has decreased functional residual capacity (FRC), decreased compliance, and increased work of breathing. This leads to:

1. Severe V/Q mismatch and right-to-left shunting: Deoxygenated blood bypasses non-ventilated alveoli.
2. Hypoxia, hypercapnia, and mixed acidosis: Acidosis and hypoxia trigger pulmonary vasoconstriction, which increases pulmonary vascular resistance (PVR) and worsens right-to-left shunting through the patent ductus arteriosus (PDA) and foramen ovale.
3. Hyaline membrane formation: Alveolar ischemia and high shear forces damage epithelial and endothelial cells, leading to transudation of proteinaceous fluid into the alveoli, forming "hyaline membranes" that further block gas diffusion.

Risk Factors

• Prematurity (the single greatest risk factor).
• Maternal diabetes: High fetal insulin levels directly antagonize the stimulatory effects of cortisol on surfactant synthesis in type II cells.
• Perinatal asphyxia: Hypoxia and acidosis impair surfactant synthesis and release.
• Male gender and multiple gestations.
• Cold stress: Increases metabolic rate and consumes oxygen/glucose needed for surfactant production.

Clinical Presentation

Symptoms present immediately at birth or within the first minutes of life:

• Expiratory grunting: A compensatory mechanism where the infant exhales against a partially closed glottis. This increases expiratory resistance, maintaining positive airway pressure and preventing alveolar collapse.
• Nasal flaring: Reduces upper airway resistance.
• Retractions (subcostal, intercostal, substernal): Reflects the high negative intrapleural pressure required to expand compliant chest walls against stiff, non-compliant lungs.
• Tachypnea and cyanosis in room air.

Diagnostic Imaging

Chest radiography reveals:

• Fine, diffuse reticulogranular pattern: Often described as a "ground-glass" appearance, representing collapsed alveoli interspersed with patent bronchioles.
• Air bronchograms: Dilated, air-filled bronchi outlined against the dense, non-aerated lung tissue.
• Low lung volumes: Under-expansion of the lungs, typically with the diaphragms elevated to the level of the 7th posterior rib or higher.

Clinical Management

1. Antenatal Corticosteroids: Administration of betamethasone (two doses of 12 mg IM, 24 hours apart) or dexamethasone to pregnant women at risk of preterm delivery between 24 and 34 weeks gestation. This stimulates type II cell maturation and surfactant production, significantly reducing the incidence and severity of RDS.
2. Non-Invasive Support: Early application of CPAP (6 to 8 cmH2O) in the delivery room is the standard of care to establish FRC and avoid mechanical ventilation.
3. Surfactant Replacement Therapy: Indicated for infants with progressive RDS who meet criteria (e.g., CPAP > 6 cmH2O and FiO2 > 30% to maintain target saturation).
   • Administration Techniques:
     • Endotracheal Intubation: Intubation, administration of surfactant (e.g., poractant alfa [Curosurf] at 2.5 mL/kg, or calfactant [Infasurf] at 3 mL/kg (or 105 mg/kg)) via an inline catheter, and mechanical ventilation.
     • INSURE (Intubate-Surfactant-Extubate): Intubation, surfactant delivery, and immediate extubation to CPAP.
     • LISA (Less Invasive Surfactant Administration) / MIST (Minimally Invasive Surfactant Therapy): Insertion of a thin, semi-rigid catheter through the vocal cords under direct visualization while the infant remains on CPAP, allowing surfactant administration during spontaneous breathing.
   • Complications:
     • Acute: Transient airway obstruction, bradycardia, desaturation, hypocapnia (due to rapid improvement in lung compliance and over-ventilation if ventilator settings are not quickly weaned).
     • Pulmonary Hemorrhage: A severe risk in extremely low birth weight (ELBW) infants. The rapid decrease in PVR following surfactant therapy increases left-to-right shunting through a PDA. This sudden increase in pulmonary blood flow can overwhelm the pulmonary capillary bed, leading to hemorrhagic edema.

---

Comparison: TTN vs. RDS

---

Clinical Pearls & Exam Traps

• The GBS Pneumonia Mimic: Group B Streptococcus (GBS) pneumonia can look radiographically identical to RDS (reticulogranular pattern). On the exam, if an infant has "RDS" but is term, or has associated maternal risk factors (fever, rupture of membranes >18 hours), GBS pneumonia must be suspected, and antibiotics (ampicillin and gentamicin) should be started immediately.
• Hyperoxygenation Risk: Following surfactant administration, lung compliance can improve in minutes. Failure to quickly wean the ventilator's peak inspiratory pressure (PIP) and FiO2 can lead to hyperoxia (risk of Retinopathy of Prematurity) and hypocarbia (which causes cerebral vasoconstriction, increasing the risk of periventricular leukomalacia).